These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 23046417)

  • 1. Impact of different dimethyl sulphoxide concentrations on cell recovery, viability and clonogenic potential of cryopreserved peripheral blood hematopoietic stem and progenitor cells.
    Smagur A; Mitrus I; Giebel S; Sadus-Wojciechowska M; Najda J; Kruzel T; Czerw T; Gliwinska J; Prokop M; Glowala-Kosinska M; Chwieduk A; Holowiecki J
    Vox Sang; 2013 Apr; 104(3):240-7. PubMed ID: 23046417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the cryoprotective solutions based on human albumin vs. autologous plasma: its effect on cell recovery, clonogenic potential of peripheral blood hematopoietic progenitor cells and engraftment after autologous transplantation.
    Smagur A; Mitrus I; Ciomber A; Panczyniak K; Fidyk W; Sadus-Wojciechowska M; Holowiecki J; Giebel S
    Vox Sang; 2015 May; 108(4):417-24. PubMed ID: 25753814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autologous peripheral blood progenitor cells cryopreserved with 5 and 10 percent dimethyl sulfoxide alone give comparable hematopoietic reconstitution after transplantation.
    Akkök CA; Liseth K; Nesthus I; Løkeland T; Tefre K; Bruserud O; Abrahamsen JF
    Transfusion; 2008 May; 48(5):877-83. PubMed ID: 18298599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of different DMSO concentrations for cryopreservation of autologous peripheral blood stem cell grafts does not have any major impact on levels of leukocyte- and platelet-derived soluble mediators.
    Akkök CA; Liseth K; Hervig T; Ryningen A; Bruserud Ø; Ersvaer E
    Cytotherapy; 2009; 11(6):749-60. PubMed ID: 19878061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A faster reconstitution of hematopoiesis after autologous transplantation of hematopoietic cells cryopreserved in 7.5% dimethyl sulfoxide if compared to 10% dimethyl sulfoxide containing medium.
    Mitrus I; Smagur A; Giebel S; Gliwinska J; Prokop M; Glowala-Kosinska M; Chwieduk A; Sadus-Wojciechowska M; Tukiendorf A; Holowiecki J
    Cryobiology; 2013 Dec; 67(3):327-31. PubMed ID: 24125911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful cryopreservation of purified autologous CD34+ cells: influence of freezing parameters on cell recovery and engraftment.
    Beaujean F; Bourhis JH; Bayle C; Jouault H; Divine M; Rieux C; Janvier M; Le Forestier C; Pico JL
    Bone Marrow Transplant; 1998 Dec; 22(11):1091-6. PubMed ID: 9877272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pentaisomaltose, an Alternative to DMSO. Engraftment of Cryopreserved Human CD34
    Svalgaard JD; Talkhoncheh MS; Haastrup EK; Munthe-Fog L; Clausen C; Hansen MB; Andersen P; Gørløv JS; Larsson J; Fischer-Nielsen A
    Cell Transplant; 2018 Sep; 27(9):1407-1412. PubMed ID: 30056762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term storage of peripheral blood stem cells frozen and stored with a conventional liquid nitrogen technique compared with cells frozen and stored in a mechanical freezer.
    McCullough J; Haley R; Clay M; Hubel A; Lindgren B; Moroff G
    Transfusion; 2010 Apr; 50(4):808-19. PubMed ID: 19912586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The viability of cryopreserved PBPC depends on the DMSO concentration and the concentration of nucleated cells in the graft.
    Liseth K; Abrahamsen JF; Bjørsvik S; Grøttebø K; Bruserud Ø
    Cytotherapy; 2005; 7(4):328-33. PubMed ID: 16162454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction of DMSO concentration in cryopreservation mixture from 10% to 7.5% and 5% has no impact on engraftment after autologous peripheral blood stem cell transplantation: results of a prospective, randomized study.
    Mitrus I; Smagur A; Fidyk W; Czech M; Prokop M; Chwieduk A; Glowala-Kosinska M; Czerw T; Sobczyk-Kruszelnicka M; Mendrek W; Michalak K; Sadus-Wojciechowska M; Najda J; Holowiecki J; Giebel S
    Bone Marrow Transplant; 2018 Mar; 53(3):274-280. PubMed ID: 29269805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of the effect of cryoprotectant medium composition to viability of autologous hematopoietic cells collected by leukapheresis.
    Kozlowska-Skrzypczak M; Kubiak A; Bembnista E; Matuszak P; Komarnicki M
    Transplant Proc; 2014 Oct; 46(8):2535-8. PubMed ID: 25380858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cryopreservation of peripheral blood progenitor cells: characteristics of suitable techniques.
    Sputtek A; Jetter S; Hummel K; Kühnl P
    Beitr Infusionsther Transfusionsmed; 1997; 34():79-83. PubMed ID: 9356660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cryopreservation of hematopoietic stem and progenitor cells amplified ex vivo from cord blood CD34+ cells.
    Duchez P; Chevaleyre J; Brunet de la Grange P; Vlaski M; Boiron JM; Wouters G; Ivanovic Z
    Transfusion; 2013 Sep; 53(9):2012-9. PubMed ID: 23227804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis and cryopreservation of hematopoietic stem and progenitor cells from umbilical cord blood.
    Meyer TP; Hofmann B; Zaisserer J; Jacobs VR; Fuchs B; Rapp S; Weinauer F; Burkhart J
    Cytotherapy; 2006; 8(3):265-76. PubMed ID: 16793735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Should the standard dimethyl sulfoxide concentration be reduced? Results of a European Group for Blood and Marrow Transplantation prospective noninterventional study on usage and side effects of dimethyl sulfoxide.
    Morris C; de Wreede L; Scholten M; Brand R; van Biezen A; Sureda A; Dickmeiss E; Trneny M; Apperley J; Chiusolo P; van Imhoff GW; Lenhoff S; Martinelli G; Hentrich M; Pabst T; Onida F; Quinn M; Kroger N; de Witte T; Ruutu T;
    Transfusion; 2014 Oct; 54(10):2514-22. PubMed ID: 24964911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determining post-thaw CD34+ cell dose of cryopreserved haematopoietic progenitor cells demonstrates high recovery and confirms their integrity.
    Reich-Slotky R; Colovai AI; Semidei-Pomales M; Patel N; Cairo M; Jhang J; Schwartz J
    Vox Sang; 2008 May; 94(4):351-7. PubMed ID: 18179677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of lower concentrations of dimethyl sulfoxide on cryopreservation of autologous hematopoietic stem cells: a systematic review and meta-analysis of controlled clinical studies.
    Bennett B; Hanotaux J; Pasala AR; Hasan T; Hassan D; Shor R; Allan DS; Maganti HB
    Cytotherapy; 2024 May; 26(5):482-489. PubMed ID: 38416086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Engraftment with peripheral blood stem cells using noncontrolled-rate cryopreservation: comparison with autologous bone marrow transplantation.
    Rosenfeld CS; Gremba C; Shadduck RK; Zeigler ZR; Nemunaitis J
    Exp Hematol; 1994 Mar; 22(3):290-4. PubMed ID: 7509292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of cryopreserved murine and human hematopoietic stem and progenitor cells designated for transplantation.
    Balint B; Ivanović Z; Petakov M; Taseski J; Vojvodić D; Jovcić G; Bugarski D; Marjanović S; Malesević M; Stojanović N
    Vojnosanit Pregl; 1999; 56(6):577-85. PubMed ID: 10707606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparison of different cryopreservation systems for peripheral blood stem cells].
    Huang YZ; Shen JL; Yang PD; Wu NH; Tang XF; Gong LZ; Cen J; Wang LX; Wang N; Zheng PH
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2008 Feb; 24(1):125-8. PubMed ID: 21141576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.